Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China’s BeBetter Medicine and PharmaEngine of Taiwan Form Cancer JV

publication date: Jan 3, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Guangzhou BeBetter Medicine Technology has signed a collaborative research agreement with Taiwan's PharmaEngine to develop new chemical entities that address predefined oncology targets. BeBetter will own China rights to any discoveries, while PharmaEngine will be able to market the products in the rest of the world. BeBetter will undertake discovery of optimized NCEs for IND-enabling studies. PharmaEngine will be responsible for their development and commercialization. More details....

Stock Symbol: (TWO: 4162)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners